Soleil Boughton compensation by year
Hims & Hers Health Summary Compensation Table · all 7 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Salary | $327,500 | $359,844 | $371,437 | $425,000 | $415,700 | $460,000 | $464,375 |
| Bonus | — | — | $815,518 | $0 | $0 | $0 | $0 |
| Stock awards | — | $647,106 | $1,532,529 | $874,997 | $3,833,310 | $3,686,385 | $4,024,269 |
| Option awards | $215,618 | $1,266,142 | — | $2,299,110 | $450,061 | $0 | $0 |
| Non-equity incentive | — | — | — | $354,656 | $510,000 | $523,951 | $305,065 |
| Pension and deferred compensation | — | — | — | — | $0 | $0 | $0 |
| All other | — | — | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 |
| Total | $543,118 | $2,273,092 | $2,722,484 | $3,956,763 | $5,212,071 | $4,673,336 | $4,796,709 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Hims & Hers Health, Inc. DEF 14A filed April 28, 2026, accession 0001773751-26-000060, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Hims & Hers Health, Inc. filed document, accession 0001773751-26-000060. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 136,897 | $4,445,046 | — |
| RSU | 108,891 | $3,535,691 | — |
| PSU | 82,964 | $2,693,841 | — |
| RSU | 80,377 | $2,609,841 | — |
| RSU | 61,115 | $1,984,404 | — |
| RSU | 10,916 | $354,443 | — |
| Option | 40,376 | — | $5.01 |
| Option | 23,110 | — | $11.53 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Hims & Hers Health, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
18 Form 4 lines since the FY2025 proxy (filed April 28, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-28 | Sale | 10b5-1 | 3,462 | $27.60 | 293,886 |
| 2026-10-14 | Sale | 10b5-1 | 3,461 | $29.06 | 297,348 |
| 2026-09-30 | Sale | 10b5-1 | 3,461 | $29.17 | 300,809 |
| 2026-09-16 | Sale | 10b5-1 | 6,236 | $27.86 | 304,270 |
| 2026-09-02 | Sale | 10b5-1 | 3,458 | $28.33 | 310,506 |
| 2026-08-19 | Sale | 10b5-1 | 25,111 | $27.55 | 313,964 |
| 2026-08-14 | Exercise or conversion | — | 42,261 | — | 360,575 |
| 2026-08-14 | Exercise or conversion derivative | — | 12,223 | $0.00 | 24,446 |
The 8 most recent of 18 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Hims & Hers Health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mohamed Elshenawy | Chief Technology Officer | $60,869,746 |
| Andrew Dudum | Chief Executive Officer and Chairman | $22,958,907 |
| Nader Kabbani | Former Chief Operating Officer | $14,862,305 |
| Yemi Okupe | Chief Financial Officer | $8,398,808 |
| Melissa Baird | Former Chief Operating Officer | $8,392,871 |
| Mike Chi | Chief Operating Officer (previously Chief Commercial Officer) | $7,727,713 |
| Soleil Boughton · this page | Chief Legal Officer | $4,796,709 |
Soleil Boughton's compensation dossier, Hims & Hers Health
You have read Soleil Boughton's totals and holdings. The dossier adds each equity grant Hims & Hers Health disclosed for Soleil Boughton and Hims & Hers Health's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Hims & Hers Health compensation record
free company briefThis page is one person within Hims & Hers Health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Hims & Hers Health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Hims & Hers Health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Hims & Hers Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order HIMS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.